Background: During exercise as pulmonary blood flow rises, pulmonary capillary blood volume increases and gas exchange surface area expands through distention and recruitment. We have previously demonstrated that pulmonary capillary recruitment is limited in COPD patients with poorer exercise tolerance. Hypoxia and endothelial dysfunction lead to pulmonary vascular dysregulation possibly in part related to nitric oxide related pathways. Purpose: To determine if increasing dietary nitrate might influence lung surface area for gas exchange and subsequently impact exercise performance. Methods: Subjects had stable, medically treated COPD (n = 25), gave informed consent, filled out the St George Respiratory Questionnaire (SGRQ), had a baseline blood draw for Hgb, performed spirometry, and had exhaled nitric oxide (exNO) measured. Then they performed the intra-breath (IB) technique for lung diffusing capacity for carbon monoxide (DLCO) as well as pulmonary blood flow (Qc). Subsequently they completed a progressive semi-recumbent cycle ergometry test to exhaustion with measures of oxygen saturation (SpO 2 ) and expired gases along with DLCO and Qc measured during the 1st work load only. Subjects were randomized to nitrate supplement group (beetroot juice) or placebo group (black currant juice) for 8 days and returned for repeat of the above protocol. Results: Exhaled nitric oxide levels rose > 200% in the nitrate group (p < 0.05) with minimal change in placebo group. The SGRQ suggested a small fall in perceived symptom limitation in the nitrate group, but no measure of resting pulmonary function differed post nitrate supplementation. With exercise, there was no influence of nitrate supplementation on peak VO 2 or other measures of respiratory gas exchange. There was a tendency for the exercise DLCO to increase slightly in the nitrate group with a trend towards a rise in the DLCO/ Qc relationship (p = 0.08) but not in the placebo group. The only other significant finding was a fall in the exercise blood pressure in the nitrate group, but not placebo group (p < 0.05). Conclusion: Despite evidence of a rise in exhaled nitric oxide levels with nitrate supplementation, there was minimal evidence for improvement in exercise performance or pulmonary gas exchange surface area in a stable medically treated COPD population.
Introduction
Chronic obstructive lung disease (COPD) typically develops over many years of smoke inhalation developing into a systemic syndrome that includes inflammation, oxidative stress, insulin resistance, sympathetic activation, and hypoxemia [1, 2] . These coexisting issues have been shown to be associated with endothelial dysfunction influencing vascular health. In addition, there is some evidence that the severity of lung dysfunction may be in parallel to the severity of endothelial dysfunction [3] . The pulmonary circulation may be particularly sensitive to endothelial dysfunction and in conjunction with regions of ventilation inhomogeneity, hypoxic pulmonary vasoconstriction develops which further contributes to vascular dysregulation, remodeling, destruction, and pulmonary hypertension [4] [5] [6] . Some of the dysregulation may be reversible as suggested by reported benefits from drugs such as sildenafil, which works through nitric oxide dependent pathways [7] . Nitric oxide synthesis may also fall due to oxygen substrate limitation as a reduction in NO has been associated with the rise in pulmonary pressures at altitude.
We have previously demonstrated that in a heterogeneous population of COPD patients, lung diffusing capacity for carbon monoxide (DLCO) assessed at rest was better associated with exercise tolerance than more traditional measures of lung mechanics (e.g., FEV 1 ) [8] . In addition, the ability to expand the pulmonary capillary bed as implied by the rise in DLCO with exercise was also preserved in patients with the greatest exercise capacity, suggesting that the pulmonary vasculature plays an important role in exercise tolerance in this population [9] . Other methods have been used to augment nitric oxide pathways and improve endothelial function. Supplements such as L-Arginine or sources of inorganic nitrate (NO 3 − ) (e.g., beetroot juice or sodium nitrate [NaNO3 -]) have been used. Several studies have demonstrated modest benefits pertaining to cardiovascular health, such as reducing blood pressure (BP), enhancing blood flow, and elevating the driving pressure of oxygen in the microcirculation to areas of hypoxia or exercising tissue while other studies have shown no or minimal benefit [10] [11] [12] [13] . Nitric oxide however also plays an important role as an inflammatory mediator. The fraction of exhaled NO (FENO) has been used in asthma to establish the correct diagnosis [14, 15] , predict response to therapy [16, 17] , titrate medications [18, 19] , and predict exacerbation [20] [21] [22] . On the other hand, studies describing the levels of FENO in patients with COPD are not very conclusive and measurement of nitric oxide in COPD, unlike asthma, is not universally recommended [23] [24] [25] .
Thus, the primary focus of this study was to use an inorganic nitrate supplement, beetroot juice, in a stable medically treated COPD population to determine if this might improve lung diffusing capacity and subsequently exercise performance. We hypothesized that improving nitric oxide production in this population may improve the ability to recruit or distend pulmonary capillaries and therefore improve exercise capacity.
Methods

Subjects
The study was reviewed and approved by the Western Institutional Review Board (WIRB, study number 1153374). Patients with a history of COPD who were able to complete pulmonary function testing and perform exercise testing were offered enrollment. Inclusion criteria included a history of established mild to severe COPD, on stable medications without any recent exacerbation (within 3 months). Exclusion criteria included oxygen dependence, an inability to exercise, or a BMI > 42. Prior to participation, the study goals and requirements were reviewed with the patients. If willing to participate, they signed informed consent.
Overview of study
After reporting to the outpatient clinic, study participants filled out the St. George's Respiratory symptom questionnaire, performed pulmonary function testing (PFTs) which included resting measures of maximal lung volumes and flow rates using classical spirometry [26] [27] [28] [29] . In addition, the assessment of lung diffusing capacity for carbon monoxide (DLCO) was obtained using the classical single breath (SB) technique and was also obtained using the intra-breath method (IB) which included a measure of pulmonary blood flow (Qc) [30] . A small blood sample was obtained prior to testing for assessment of hemoglobin in order to correct the measures of DLCO. Subjects subsequently performed cardiopulmonary exercise testing (CPET) using the CareFusion metabolic cart (San Diego, CA) on a semi-recumbent cycle ergometer (Lode, Netherlands). The test protocol started with 20 W for both men and women and increased by 10 W every 2 min. Prior to exercise testing, subjects were instrumented with a 12 lead ECG, and a forehead pulse oximeter for peripheral arterial oxygen saturation (SaO 2 ) for continuous monitoring. Subjects wore a nose clip and breathed on a mouthpiece for measurement of gas exchange during the exercise test. During the last 30 s of each workload, a 12 lead ECG was recorded, blood pressure (BP) assessed, Borg's perceived dyspnea score (0-10 scale) and rate of perceived exertion (RPE) were rated by subjects, and an average of the HR and SaO 2 over this period was determined. Subjects were encouraged to exercise to near exhaustion by achieving an RPE of 17-18 on the 6-20 scale or a dyspnea score ≥7 on the 0-10 Borg scale. Upon reaching peak exercise subjects performed active recovery where they continued to pedal with no resistance and remained on the mouthpiece for 1 min. After this the subject stopped pedaling and were given time for HR and BP to return to baseline before being dismissed. The flow chart of the study is shown in Fig. 1. 
Pulmonary function and single breath DLCO
Spirometry was performed using pneumotachograph-based pulmonary function equipment that had passed evaluation using 24-wavefroms recommended by the American Thoracic Society [27, 31] . Classic single breath DLCO was determined using a commercial instrument following the recommendations of the ATS/ERS.
Intra-breath lung diffusing capacity and pulmonary blood flow (Qc)
Pulmonary Blood Flow (Qc) and DLCO were measured using inert and soluble gases on the CareFusion Vmax system using an intra-breath method [30, 32] . For this method, subjects were asked to breathe on a mouthpiece while wearing a nose clip. Subjects were instructed to exhale to near residual volume (RV) and then were switched into an inspiratory reservoir and took a full inhalation of a test gas mixture containing 0.3% carbon monoxide (CO), 0.3% methane, 0.3% acetylene, 21% O 2 , and balance N 2 . Subjects were coached to exhale at a steady rate until they were back near RV. From the rate of disappearance of CO and acetylene in comparison to the inert gas methane, the rate of disappearance of CO and acetylene were determined. This rate of disappearance of CO was used to calculate DLCO. Since acetylene does not bind to hemoglobin, the rate of its disappearance is limited primarily by the flow of blood through the lungs, thereby providing a measure of Qc. The measure of IBDLCO and IBQc was practiced several times at rest in each subject until reproducible values were obtained and performed near the end of the first workload in triplicate. If necessary the first work load was extended before incrementing the cycle ergometer resistance in order to obtain reproducible measures.
St. George's respiratory symptom questionnaire
The SGRQ is a 50-item questionnaire developed to measure health status (quality of life, QOL) in patients with diseases causing airway obstruction. Scores are calculated for three domains: Symptoms, Activity and Impacts (Psycho-social) as well as a total score. Psychometric testing has demonstrated its repeatability, reliability and validity. Sensitivity has been demonstrated in clinical trials [29] .
Gas exchange, ventilation and lung mechanics
During exercise testing oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ), breathing frequency (fb), tidal volume (V t ), minute ventilation (V E ) and derived variables were measured continuously and/or calculated using the CareFusion low resistance open circuit automated metabolic system. In particular, measures associated with ventilation and perfusion matching or pulmonary vascular health were determined. These were the partial pressure of mixed expired CO 2 (P et CO 2 ), end tidal CO 2 (P e CO 2 ), and their relative ratio (P e CO 2 /P et CO 2 ) (associated with ventilation and perfusion matching in the lungs and reported to be reduced in COPD patients with a negative slope during exercise in patients with pulmonary hypertension). Also measured were GxCap, a noninvasive estimate of pulmonary vascular capacitance calculated as oxygen pulse multiplied by P et CO 2 (oxygen pulse tracks stroke volume and P et CO 2 has been shown to reasonably track pulmonary arterial pressure), and ventilatory efficiency which is VE/VCO 2 [33, 34] .
Dietary supplementation
Patients were randomized to receive either beetroot or black currant juice. Beetroot was purchased from Beet It (www.beet-it.us) and black currant juice from Knudsen (www.rwknudsen.com). After randomization, the beetroot juice group of patients received 8 bottles of juice, each made of 70 ml of beetroot juice plus 180 ml of black currant juice (total 250 ml). The placebo group received 8 bottles of juice, each made of 70 ml of water and 180 ml of black currant juice (total 250 ml). All the patients were blinded to their type of juice. Each patient had to take one bottle of juice per day for eight consecutive days, the last bottle being the day of their return for the follow up CPET study. Patients were called every day to remind them of taking their juice.
Exhaled nitric oxide measurement
Nitric oxide in the exhaled air was measured using NIOX VERO system (www.niox.com). To make a measurement, a filter was placed on the mouthpiece. The subject then exhaled steadily for approximately 10 s and was guided by a visual monitor on the device screen to ensure the exhalation was uniform and steady. When maneuver was complete, the screen gave an indication and the final value in parts per billion was shown on the screen.
Statistics
We were interested in exercise limitation in the COPD population and the potential role of the alveolar-capillary bed, lung surface area for gas exchange or the ability to expand this bed as a mediating factor. Thus our primary measures were the change in IBDLCO and the change in IBDLCO in proportion to IBQc across subjects and the relationship to exercise or aerobic capacity; primarily peak VO 2 . Thus we used multiple regression and correlational analysis to asses these relationships. In addition, general descriptive statistics were used to define our group and paired t-tests to evaluate changes with exercise. For variables found not to be normally distributed, a Wilcoxon signed rank test was used to test for differences between the groups using an α = 0.05. Tables 1-3 give the baseline subject characteristics and standard spirometry values along with DLCO, measures of pulmonary blood flow and exhaled nitric oxide levels. The two groups (nitrate group vs placebo) were relatively well matched for age, sex, smoking history, symptoms and disease severity based on the GOLD (Global Initiative for Chronic Obstructive Lung Disease) classification and measures of lung function. In addition they were on similar distribution of medications. Values are also reported after receiving either nitrate supplementation or placebo. The only significant changes observed were an increase in the exhaled nitric oxide levels in the nitrate group and a small drop in the SGRQ (p < 0.05). No other significant changes were observed either between groups or post nitrate or placebo intervention in these measures.
Results
Subject characteristics and measures of pulmonary function
Exercise responses
Tables 4-6 display the mean exercise data for lung diffusing capacity and pulmonary blood flow, submaximal (matched work load only) exercise ventilatory, cardiovascular and gas exchange responses and similar measures obtained at peak exercise. There was a trend for a rise in the submaximal DLCO (+14%) and expressed relative to Qc (+20%) in the nitrate group (p = 0.08), with no evidence of change in the placebo group (Fig. 2 ). There were no other changes noted in cardiovascular responses or measures of pulmonary gas exchange or breathing pattern post nitrate or placebo supplementation during submaximal exercise.
There was no difference in peak exercise performance post nitrate or placebo supplementation. There was also no observable impact of nitrate supplementation on other key measures of breathing pattern, respiratory gas exchange or other variables associated with pulmonary vascular function during heavier exercise. The only measure that reached statistical significance was a reduced blood pressure at peak exercise in the nitrate supplemented group, but not the placebo group (Fig. 3 ). There was a tendency for the beetroot juice group to have elevated pretreatment exercise blood pressures relative to the placebo group; however, 8 of 12 in the beetroot juice group demonstrated a drop post treatment at peak exercise while only 2 in the placebo group demonstrated a fall in exercise blood pressure post treatment (Fig. 4) . Differences in blood pressure between the two groups was also assessed with a Wilcoxon Signed Rank Test showing that there was a difference in peak blood pressure response with juice vs placebo.
Discussion
Chronic obstructive pulmonary disease is associated with remodeling and destruction of the pulmonary vasculature. This leads to declines in functional lung surface area for respiratory gas exchange and a reduced ability to expand it with exercise. This inability to recruit or distend pulmonary capillaries has thus been linked to exercise limitation in this population [9] . Endothelial dysfunction is a part of the pathophysiology of COPD, in part related to altered nitric oxide regulation [35, 36] . Therefore we tested the hypothesis that supplementation with nitrates may improve nitric oxide formation, enhance endothelial function and improve lung surface area for respiratory gas exchange. We found that while we had evidence for increased NO formation from exhaled measurements, there was no significant impact on resting measures of airway or pulmonary vascular function. There were trends towards improved pulmonary vascular recruitment with exercise in the nitrate supplement group and evidence for reductions in systemic blood pressure, but the change in DLCO was not associated with changes in other noninvasive indices of respiratory gas exchange during exercise or an improvement in exercise capacity. Interestingly there was a trend towards a reduction in symptoms in the nitrate group relative to the placebo group, however the mechanism for this remains unclear and larger numbers would be needed to confirm this finding. Thus while there was some evidence of a systemic influence of nitrate supplementation with inorganic supplementation, there was no definitive benefit relative in pulmonary function or exercise performance relative to placebo.
NO is a signaling molecule with multiple functions including regulation of vascular tone, mitochondrial respiration and skeletal muscle function. These factors are important in the physiological response to exercise and relative to our hypothesis for the recruitment of the pulmonary vasculature with exercise. NO is produced in two primary ways in man. The best known is the classical L-arginine nitric oxide synthase (NOS) pathway which is oxygen dependent. The second is the enterosalivary pathway and is oxygen independent. Ultimately some nitrite is absorbed into the circulation where it acts as a storage pool for subsequent NO production. The conversion of nitrite to NO is expedited in conditions of acidosis or hypoxemia which likely occurs in regions of the pulmonary vasculature in COPD patients, especially during exercise [37] [38] [39] .
We have recently demonstrated that resting DLCO or resting DLCO relative to pulmonary blood flow (DLCO/Qc) has been predictive of exercise performance in a moderate to moderately severe COPD population [8] . In addition, our preliminary data show that the ability to (52) . Qc = Pulmonary Blood Flow. Hgb = Hemoglobin, IBDLCO and SBDLCO = intra-breath and single breath lung diffusing capacity for carbon monoxide.
• Significant difference between Nitrate group and Placebo group at baseline p < 0.05. # Significant difference between pre and post nitrate or placebo p < 0.05.
expand the pulmonary capillary bed during exercise has also been an important factor in determining exercise capacity in this group [9] . DLCO is reduced in COPD likely due to destruction of alveolar septum and the pulmonary capillary bed; other contributing causes are remodeling, ventilation-perfusion mismatch, and hypoxic pulmonary vasoconstriction. A fall in NO due to less synthesis of NO caused by oxygen substrate limitation or oxygen sensitivity of the NO synthase, could also contribute to the immediate rise in pulmonary artery pressure upon arrival at altitude as a consequence of a reduced capacity to vasodilate [40] . Thus despite the remodeling, there are likely regulatory mechanisms influencing pulmonary vascular recruitment in this population and thus potentially reversible. The impact of altering nitric oxide pathways on exercise capacity in COPD patients is variable. Work by Lederer [41] did not demonstrate improvement in 6 min walk distance or peak exercise VO 2 with 4 weeks of sildenafil three times daily. The authors found a reduction in quality of life and evidence for an increased alveolar to arterial oxygen difference with sildenafil. Similar findings were found by Holverda et al. [7] with acute administration of sildenafil without improvement in exercise performance in COPD patients with or without pulmonary hypertension. However, other studies have found improvements in 6 min walk distance in patients with COPD taking sildenafil [42] . Thus the impact of sildenafil is controversial. However, it is possible that the PDE-5 inhibitors such as sildenafil, may override to some extent the important vasoregulatory mechanisms that attempt to improve some level of ventilation to perfusion mismatch in the lungs and it is possible that higher doses may in fact be counterproductive [7] .
Impact of dietary supplementation of inorganic nitrates
Studies have demonstrated modest benefits pertaining to cardiovascular health, such as reducing blood pressure (BP), enhancing blood flow, and elevating the driving pressure of oxygen in the microcirculation to areas of hypoxia or exercising tissue [43, 44] . However, there are limited studies in the COPD population with mixed findings.
Berry et al. studied effects of dietary nitrate supplementation via beetroot juice on the submaximal exercise capacity of COPD patients. In their randomized, single-blind, crossover design, beetroot juice was [52] . Qc = Pulmonary Blood Flow. EXIBDLCO/ RSTDLCO is the exercise intra-breath DLCO divided by the resting intra-breath DLCO.
Table 5
Cardiopulmonary Responses to Submaximal Exercise in COPD Patients receiving nitrate supplement (n = 12) or placebo (n = 13) (Mean ± SD). • Significant difference between Nitrate group and Placebo group at baseline p < 0.05. # Significant difference between pre and post nitrate or placebo p < 0.05.
given [12] . Relative to placebo, beetroot ingestion caused significant elevation of plasma NO 3 by 938% and NO 2 by 379%. Median exercise time was significantly increased and blood pressure was also significantly reduced. No other variables were significantly different between the two groups. In another study, Leong et al. performed a double-blind, computer-randomized placebo control crossover trial to study the effects of dietary nitrate on exercise endurance in stable moderate COPD subjects [45] . Patients underwent an incremental shuttle walk test to determine VO 2 max followed by randomization to placebo or beetroot groups. Subjects performed an endurance shuttle walk test at 85% VO 2 max after randomization. Then they took the sample juice for 3 days and on the 4th day wash out there was a cross over between the groups. Again blood pressure was reduced with ingestion of beetroot juice. End shuttle walk test distance and time to fatigue improved but did not reach statistical significance. In a study by Kerley et al., an increase in incremental shuttle walk distance after consumption of high nitrate juice (25 m) compared to low nitrate juice (14 m) was noted. The improvement in exercise capacity was associated with statistically significant increases in serum nitrate and nitrite levels and a significant lowering of resting blood pressure [46] . These studies show that the effects of beetroot on exercise performance in COPD is not consistent and results are mixed at best, although lowering of blood pressure probably due to vasodilatory effects was a common finding. There could be several reasons for the inconsistencies. The factors that have been suggested include deconditioning, hypoxia, hypercapnia, systemic inflammation, nutritional imbalance and medication therapy to name a few. At the physiological level, mitochondrial dysfunction and redox imbalance seem to contribute to the conflicting results that are obtained at each trial. For example, oxidative stress shadows nitric oxide effects and is likely to be involved in the respiratory muscle dysfunction in severe COPD [47] . Epigenetic modification may also play a role in muscle dysfunction in COPD. The epigenetic modifications recognized so far include DNA methylation, histone acetylation and methylation, and non-coding RNAs such as microRNAs [48] . These complex, interwoven factors makes prediction of dietary nitrate supplementation difficult and at times unpredictable. It seems there are several factors that are responsible for muscle dysfunction in COPD, not to include the dose of nitrate supplementation that is not clearly identified in each patient and can be variable [49] .
Thus to summarize, use of inorganic nitrate supplement for 8 days in a mild to severe COPD population increased exhaled nitric oxide levels, mildly reduced respiratory symptoms and exercise blood pressure but did not appear to significantly impact lung surface area for gas diffusion or peak exercise capacity. There are some hints of improved DLCO relative to Qc, suggesting that perhaps a mild influence on pulmonary capillary blood volume can be contributing; however, the effect is small and did not reach statistical significance.
Limitations
There are a number of limitations regarding this study. The intrabreath maneuver, while easier to perform during exercise than the single breath-hold technique, was still challenging. Thus we were only able to obtain these data at the first workload in all individuals in triplicate. We did not have additional work levels or peak values and our conclusions are thus limited to submaximal values. It is possible that recruitment or distension of this vascular bed may change with higher workloads, however previously studies have suggested a linear influence of exercise (cardiac output) on DLCO and for many of our subjects the first work level was as much as 75% of peak work. We did however have other non-invasive gas exchange measures at peak exercise that tend to correlate to DLCO, such as V E /V CO2 ratio and the P ECO2 /P et CO 2 ratio which were not impacted by the supplement. In addition we have previously demonstrated that the O 2 pulse multiplied by the PetCO 2 was associated with pulmonary capacitance in a heart failure population and this metric was also unaffected by the supplementation. Furthermore, we were not able to separate DLCO into its component parts, Dm and Vc (membrane diffusion capacity and pulmonary capillary blood volume); however, we did measure Qc and the ratio of DLCO/Qc should be somewhat analogous to Vc. In our previous studies, this ratio tended to be more highly associated with exercise tolerance than DLCO alone [9] .
The study was also limited by relatively small numbers of stable COPD patients. Thus this may have led to some imbalance in the baseline measures between groups, such as pretreatment peak exercise blood pressure. However, no subjects were on oxygen therapy and none were on vasoactive drugs at the time of the study. While we did not obtain baseline and post supplement measures of pulmonary vascular pressures on our subjects, it is not likely our subjects had significant pulmonary hypertension as we did not observe any significant oxygen desaturation with exercise. Some of the patients were active smokers or were taking oral prednisone and these have been shown to lower FENO in COPD, but these variables were similar in each study group [50, 51] .
Finally, as previously noted by Berry et al., in addition to nitrate beetroot juice contains several potentially metabolically active compounds that could influence physiological function in patients with COPD [12] . Potentially confounding compounds may be polyphenols and/or quercetin. Though we did use a juice placebo, it is possible that beetroot juice supplementation may have influenced the outcome beyond those attributed to nitrate alone.
Thus while there were several major limitations in this study, we view these data as thought-provoking findings in a small population of COPD patients that should form the foundation for more comprehensive and larger prospective studies that may give insight into the potential benefits of enhancing nitric oxide pathways on pulmonary vascular function.
